Polderman Jorinde A W, Hollmann Markus W, DeVries J Hans, Preckel Benedikt, Hermanides Jeroen
Department of Anaesthesiology, Academic Medical Centre, Amsterdam, Netherlands
Department of Anaesthesiology and Laboratory of Experimental Intensive Care and Anaesthesiology, Academic Medical Centre, Amsterdam, Netherlands.
J Diabetes Sci Technol. 2015 Jul 21;10(1):145-50. doi: 10.1177/1932296815595985.
The glycemic response and its relation to postoperative complications following gynecologic laparotomies is unknown, although these surgeries carry a substantial risk for postoperative morbidity. Therefore, our objective was to assess the prevalence of perioperative hyperglycemia and glucose variability in women undergoing a gynecologic laparotomy.
In this prospective cohort study, capillary glucose was measured every hour during the perioperative period. The primary outcome measures were the proportion of patients with postoperative hyperglycemia (glucose >180 mg d l(-1)) and the glucose variability in the intra- and postoperative period. Postoperative complications were assessed as secondary outcome measure.
We included 150 women undergoing a gynecologic laparotomy. Perioperative hyperglycemia occurred in 33 patients without diabetes (23.4%) and in 8 patients with diabetes (89%). Glucose variability was significantly higher (mean absolute glucose change [MAG] 11 mg dl(-1) hr(-1) [IQR 8-18]) in the intraoperative compared to the postoperative period (MAG 10 mg dl(-1) hr(-1) [IQR 3-16], P = .03). Neither hyperglycemia nor glucose variability was associated with postoperative complications.
Hyperglycemia and glucose variability seem to be a minor problem during gynecologic laparotomy. Based on the current data, we would not advocate standardized glucose measurements in every patient without diabetes undergoing gynecologic laparotomy.
尽管妇科剖腹手术术后发病风险很大,但其血糖反应及其与术后并发症的关系尚不清楚。因此,我们的目的是评估接受妇科剖腹手术的女性围手术期高血糖和血糖变异性的发生率。
在这项前瞻性队列研究中,围手术期每小时测量毛细血管血糖。主要结局指标为术后高血糖(血糖>180mg/dl)患者的比例以及术中和术后的血糖变异性。术后并发症作为次要结局指标进行评估。
我们纳入了150例接受妇科剖腹手术的女性。33例无糖尿病患者(23.4%)和8例糖尿病患者(89%)出现围手术期高血糖。与术后时期相比,术中血糖变异性显著更高(平均绝对血糖变化[MAG]11mg/dl·hr[IQR 8 - 18])(术后MAG 10mg/dl·hr[IQR 3 - 16],P = 0.03)。高血糖和血糖变异性均与术后并发症无关。
在妇科剖腹手术期间,高血糖和血糖变异性似乎是一个小问题。基于目前的数据,我们不主张对每例接受妇科剖腹手术的非糖尿病患者进行标准化血糖测量。